Twilight’s Nikki Reed and filmmaker Rebecca Harrell Tickell uncover the genetic story beneath regenerative agriculture, from soil microbes to human health.
ABGC Continuing Competence Committee co-chairs Monica Marvin and Dr. Claire Davis join ABGC Executive Director Heather Rich to explain the new Learning Scenarios requirement and what genetic counselors need to know for recertification.
Dr. Troy Rohn discusses his new book, Brain Medicine, and explores how CRISPR, RNA, and precision mental health could shape the future of anxiety treatment with gene therapy.
Interviews...
Twilight’s Nikki Reed and filmmaker Rebecca Harrell Tickell uncover the genetic story beneath regenerative agriculture, from soil microbes to human health.
ABGC Continuing Competence Committee co-chairs Monica Marvin and Dr. Claire Davis join ABGC Executive Director Heather Rich to explain the new Learning Scenarios requirement and what genetic counselors need to know for recertification.
Dr. Troy Rohn discusses his new book, Brain Medicine, and explores how CRISPR, RNA, and precision mental health could shape the future of anxiety treatment with gene therapy.
Baylor Genetics’ Dr. Christine Eng and Chris Sands explore the power of whole genome sequencing when paired with multi-omic technology, like long-read sequencing, optical genome mapping, and RNA sequencing.
Beyond Inheritance author unpacks the ever-changing genome and what mutation and mosaicism reveal about genetic conditions, immunity, and aging.
Siblings Dan and Faith share their family’s experience with Sialidosis; from the decade-long hunt for a diagnosis to the groundbreaking research they are involved in.
The second installment of our Achondroplasia Series, sponsored by BioMarin, focusing on lifelong medical monitoring and care coordination with guest Dr. Ricki Carroll.
See how tools like long read sequencing, RNA sequencing, MAVEs, and AI are ethically transforming WGS to make patients lives better.
Baylor Genetics’ Chief Medical Officer Dr. Christine Eng explains how RNA sequencing complements DNA testing to unlock diagnoses for rare disease patients.
How whole genome sequencing is transforming rare disease diagnosis in Brazil featuring MGI’s Victor Camillo and Neogenomica’s Dr. João Bosco Oliveira.